source: google deepmind: our approach to bioresilience
level: technical
google deepmind and isomorphic labs have detailed their joint bioresilience program, which aims to use ai to strengthen global defenses against infectious diseases and potential misuse of biological tools. the work focuses on three areas: preventing threat actors from misusing ai models, detecting new outbreaks quickly, and responding with faster development of vaccines and treatments. over the past year, they have built more than 15 partnerships with government bodies, biosecurity organizations, and research groups.
for prevention, the companies follow a four-step safety process for models like gemini: threat modeling, evaluations, mitigations, and monitoring. they work with in-house biologists and external experts to test for risks and add safeguards. they are also adapting synthid watermarking technology to biology, which could help dna synthesis providers screen for potentially risky ai-generated sequences. in detection, the agent alphaevolve optimizes algorithms for metagenomic sequencing, making pathogen surveillance cheaper and faster. they are exploring how alphagenome and protein function annotation can detect and characterize pathogens from sequence data more quickly than traditional methods.
for response, trusted researchers will get access to google deepmind's latest ai systems to speed up vaccine design for known and novel threats. isomorphic labs has set up a focused unit to rapidly deploy its drug design engine during outbreaks, working with governments and health authorities to develop diagnostics and therapies. this effort is part of a broader strategy to manage chemical, biological, radiological, and nuclear risks, aligned with the frontier safety framework. the companies emphasize open collaboration with biosecurity labs and the scientific community to responsibly develop and deploy ai against major societal risks.
why it matters: ai-driven bioresilience can help data scientists and health authorities build proactive defenses against pandemics and biosecurity threats, making outbreak detection and drug discovery faster and more cost-effective.